Share this Scrip Asks…What Does 2021 Hold for Biopharma? Part 5: Business Environment and Strategy Scrip February 22, 2021 "A strong year is predicted for biopharma business with investment and deal making set to continue apace. Executives across industry share their forecasts for the year ahead." Read the article
"A strong year is predicted for biopharma business with investment and deal making set to continue apace. Executives across industry share their forecasts for the year ahead." Read the article